USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: METABOLIC SOLUTIONS DEVELOPMENT CO
City: KALAMAZOO
State: MI
Zip+4: -
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $280,775.00 2
STTR Phase II $2,378,645.00 2

Award List:

PPAR-sparing/free Thiazolidinediones for Treatment of Diabetes

Award Year / Program / Phase: 2010 / STTR / Phase II
Agency: HHS
Research Institution: University Of California San Diego
Principal Investigator: Rolf F. Kletzien – 304-293-2494
Award Amount: $1,242,623.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): The overall objective of our proposed research is to discover a PPARg-free thiazolidinedione (TZD) which shows antidiabetic activity in a rodent model of Type 2 diabetes and demonstrates the necessary drug-like qualities to become a clinical candidate for human… More

Evaluation of PPARgam-sparing TZDs for Treating Non-Alcoholic Fatty Liver Disease

Award Year / Program / Phase: 2011 / STTR / Phase II
Agency: HHS
Research Institution: WASHINGTON UNIVERSITY
Principal Investigator: Rolf F. Kletzien – 304-293-2494
Award Amount: $1,136,022.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease in the United States. This condition encompasses both hepatic steatosis and the more severe non-alcoholic steatohepatitis. It is now estimated that 14-24% of the general population and… More